Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US
Fanikos, John, Goldstein, Joshua N., Lovelace, Belinda, Beaubrun, Anne C., Blissett, Robert S., Aragão, Filipa
Published in Journal of medical economics (31.12.2022)
Published in Journal of medical economics (31.12.2022)
Get full text
Journal Article
S660 Cost Effectiveness of Andexanet Alfa for Major Gastrointestinal Bleeding Associated With Factor Xa Inhibitors
Cash, Brooks D., Goldstein, Joshua N., Deitelzweig, Steven, Lovelace, Belinda, Christoph, Mary J., Blissett, Robert S., Fermann, Gregory J.
Published in The American journal of gastroenterology (01.10.2021)
Published in The American journal of gastroenterology (01.10.2021)
Get full text
Journal Article
Transurethral water vapor therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cost-minimization and budget impact analysis from an Italian healthcare perspective
Blissett, Robert S, Blissett, Deirdre B, Oselin, Martina, Demaire, Clementine, Woodward, Emily, Siciliano, Michele, Torres, Esperanza, Franzoso, Francesco, Comelli, Tiziana
Published in Minerva urology and nephrology (01.06.2023)
Published in Minerva urology and nephrology (01.06.2023)
Get more information
Journal Article